Breast cancer
Conditions
Interventions
None listed
Sponsors
National Institutes for Quantum Science and Technology (QST)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Breast cancer patients who underwent carbon-ion radiotherapy with metallic marker implantation between June 2017 and February 2024.
Exclusion criteria
Exclusion criteria: Patients for whom setup time or marker positional data were not recorded Patients who declined the use of their information for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of total setup time between the supine and prone positions. | — |
Secondary
| Measure | Time frame |
|---|---|
| Marker positional deviations and trends in the supine and prone positions, and subdivided time for each step (immobilization device setup, X-ray imaging, and repositioning). | — |
Countries
Japan
Contacts
Public ContactMasaru Wakatsuki
National Institutes for Quantum Science and Technology (QST) QST Hospital
Outcome results
None listed